English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/153018
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders

AuthorsNavarro, Gemma; Morales, Paula ; Rodríguez-Cueto, Carmen; Fernández-Ruiz, Javier; Jagerovic, Nadine ; Franco, Rafael
Issue Date13-Sep-2016
PublisherFrontiers Media
CitationFrontiers in Neuroscience 10: 406 (2016)
AbstractEndocannabinoids activate two types of specific G-protein-coupled receptors (GPCRs), namely cannabinoid CB1 and CB2. Contrary to the psychotropic actions of agonists of CB1 receptors, and serious side effects of the selective antagonists of this receptor, drugs acting on CB2 receptors appear as promising drugs to combat CNS diseases (Parkinson's disease, Huntington's chorea, cerebellar ataxia, amyotrohic lateral sclerosis). Differential localization of CB2 receptors in neural cell types and upregulation in neuroinflammation are keys to understand the therapeutic potential in inter alia diseases that imply progressive neurodegeneration. Medicinal chemistry approaches are now engaged to develop imaging tools to map receptors in the living human brain, to develop more efficacious agonists, and to investigate the possibility to develop allosteric modulators.
Publisher version (URL)http://dx.doi.org/10.3389/fnins.2016.00406
URIhttp://hdl.handle.net/10261/153018
DOI10.3389/fnins.2016.00406
ISSN1662-4548
Appears in Collections:(IC) Artículos
Files in This Item:
File Description SizeFormat 
Targeting Cannabinoid CB2 Receptors.pdf1,47 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.